A European clinical trials registry for children

Paediatric and Perinatal Drug Therapy

Volumn 5, Issue 3, 2003, Pages 98-100

  Pandolfini, Chiara ^a   Bonati, Maurizio ^a   Sammons, Helen ^b   Choonara, Imti ^b   Jacqz Aigrain, Evelyne ^c   Danés, Imma ^d   Fuentes, Imma ^d   Arnau, Josep ^d  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d Fundacion Institut Catala de Farmacologia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD CARE; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; CONSULTATION; DRUG APPROVAL; DRUG INDICATION; DRUG RESEARCH; DRUG USE; EDITORIAL; EUROPE; EVIDENCE BASED MEDICINE; HEALTH CARE ORGANIZATION; HUMAN RIGHTS; LAW; MEDICAL SOCIETY; PRACTICE GUIDELINE; PUBLICATION; QUALITY OF LIFE; REGISTER;

EID: 0037804292     PISSN: 14630095     EISSN: None     Source Type: Journal    
DOI: 10.1185/146300903322012004     Document Type: Editorial

References (18)

1. Bonati M, Choonara I, Hoppu K, Pons G, Seyberth H. Closing the gap in drug therapy. Lancet 1999; 353: 1625.
2. Autret E, Bonati M, Choonara I et al. Medicines for children. Paed Perinatal Drug Ther 2000; 4: 23.
3. Still JG. The pediatric research initiative in the United States: implications for global pediatric research. Drug Inf J 2000; 34: 207-212.
4. Koren G, Kearns GL, Reed M, Pons G. Use of healthy children as volunteers in drug studies: the ethical debate. Clin Pharmacol Ther 2003; 73: 147-152.
5. Kodish E. Informed consent for pediatric research: is it really possible? J Pediatr 2003; 142: 89-90.
6. Morton NS. Ethical issues in research with children in the UK. Paed Perinatal Drug Ther 2001; 4: 135-139.
7. Note for guidance on clinical investigation of medicinal products in children. London: Medicines Control Agency, 1997.
8. Impicciatore P, Choonara I. Status of new medicines approved by the European Medicines Evaluation Agency regarding paediatric use. Br J Clin Pharmacol 1999; 48: 15-18.
9. Jong GW, Stricker BH, Choonara I, van den Anker JN. Lack of effect of the European guidance on clinical investigation of medicines in children. Acta Paediatr 2002; 91: 1233-1238.
10. Ceci A, Felisi M, Catapano M et al. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products. Eur J Clin Pharmacol 2002; 58: 495-500.
11. European Commission. Better Medicines for Children. Proposed regulatory actions on paediatric medicinal products. Brussels, February, 2002. Available at: pharmacos.eudra.org/F2/pharmacos/docs/Doc2002 /feb/cd_pediatrics_en.pdf. 2002.
12. Stern JM. Publication bias: evidence of delayed publication in a cohort study of clinical research projects. Br Med J 1997; 315: 640-645.
13. Antes G, Chalmers I. Under-reporting of clinical trials is unethical. Lancet 2003; 361: 978-979.
14. Clavenna A, Pandolfini C, Bonati M. Public disclosure of clinical trials in children. Curr Ther Res 2002; 63: 707-716.
15. Bonati M, Impicciatore P, Pandolfini C. Register of clinical trials in children must be set up. Br Med J 2000; 320: 1339.
16. Bonati M, Pandolfini C, Choonara I, Jacqz-Aigrain E, Arnau J. Something is finally moving, at least in the paediatric field... Brit Med J [e-letter] 2002 Dec [cited 2003 May 16]. Available from: URL: bmj.com/cgi/eletters/325/7376/1314#28245.
17. Development of the European register of clinical trials on medicines for children (DEC-net). 2003 [cited 2003 May 22]. Available at: URL: www.dec-net.org.
18. MetaRegister of Controlled Trials (mRCT) [cited 2003 May 22]. Available at: URL: http://controlled-trials.com/mrct.